FDA regs are not the only drivers of R&D costs

12/20/2012 | Forbes

FDA regulations are often blamed for the high cost of drug development, but drugmakers' business decisions may be the real culprits, writes Bernard Munos. FDA approval requires two successful Phase III trials, but drugmakers performed dozens of trials in support of blockbusters, whether to broaden the indication or in support of marketing, Munos writes. Moreover, the high failure rate of pre-approval Phase III trials seems to indicate that executives are pushing mediocre drug candidates through the pipeline, he writes.

View Full Article in:

Forbes

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations